Navigation Links
Telecom research leads to solar cell breakthrough
Date:2/11/2008

Semiconductor insights gained by engineering physics researchers at McMaster University for the telecommunications industry have led to a research breakthrough in the future development of high-efficiency solar cells.

The Ontario Centres of Excellence (OCE) and ARISE Technologies Corporation, a solar energy firm headquartered in Waterloo, today announced that they are investing $4.1 million to advance commercialization of McMasters research.

Rafael Kleiman and John Preston, professors of engineering physics at McMaster, discovered a patent-pending method of applying single crystal layers of compound semiconductors, such as gallium-arsenide, on single crystal silicon crystal which they expect will convert sunlight to electricity twice as efficiently as other materials systems commonly in use.

Commenting on the news, Ian MacLellan, ARISEs President and CEO remarked, This project is expected to introduce a novel way to manufacture solar cells. When combined with ARISE's proprietary silicon technology currently being developed, there is the potential to more than double traditional PV cell efficiencies.

Playing a significant role in the commercialization of McMasters important research is part of OCEs mandate to develop Ontario-based clean energy solutions, said Mark Romoff, president and CEO, Ontario Centres of Excellence. Through partnerships like this, the world will be looking at Ontario for the best manufactured solar cells for both homes and businesses.

The ability to deposit high quality single crystal layers of selected chemical elements is key to absorbing and converting more sunlight to electricity, but achieving the necessary alignment on silicon was thought to be highly improbable at a large scale. The approach of combining different materials to capture a greater share of the solar spectrum, into multi-junction photovoltaic solar cells, today uses high-cost substrates such as germanium, and has mostly been
'/>"/>

Contact: Gene Nakonechny
genen@mcmaster.ca
905-525-9140
McMaster University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Labopharm amends debt facility agreement with Hercules 50014 1Labopharm amends debt facility agreement with Hercules 50014 2Labopharm amends debt facility agreement with Hercules 50014 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 1Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 2Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 4OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 1OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 2OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 3
...To help improve the success of oyster restoration ...and Center for Environmental Science researcher Dr...in a new in-depth study to determine when oysters ...ver. Her team,s research is supported by a $750,00...dation. , Working with fellow UMCES Horn Point La...
...f women with breast cancer today are candidates fo... their breast tissue. Results of a UC Davis study,... recurs in the same breast are treated with a seco...rrent treatment recommendations and cutting the nu... were surprised to find that so many women in our ...
..., the oil industry will need more refined tools fo...before taken place, geologists say. , One such to...ment-on-the-move is deposited), derived from sedim... ago, scientists report in this week,s issue of th... entire Paleozoic Era. , "The new Paleozoic sea-l...
Other Biology News:Second lumpectomy for breast cancer reduces survival rates 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-A...eloper and provider of vaccines, announced today t...establish Sinovac (Dalian) Vaccine,Technology Co.,...lop, produce,and commercialize human-use vaccines....nce in developing and commercializing world-class ...
(Date:11/24/2009)... Ambassador to also Visit De...24, 2009 -- , , ,Who: David Appia, French Ambassad...CEO of the Invest in France Agency, , , , ,What: ...o discuss recent pro-business initiatives adopted ... and academic landscape for innovation and develop...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCa...will be presenting at the NASDAQ OMX conference on...:45 AM US/CST. Interested parties may listen via l... http://inve s tor.sig m a a ldrich.com/ ...is file. ,, About Sigma-Aldrich: Sigma-Al...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-As...e Food & Drug Administration (SFDA) has approv...for its oral insulin project,(Nodlin), an innovati...,approval allows Biolaxy to initiate its first pha...rder characteristic of high blood glucose and poor...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... the Recently Released Strong Results from the, La...ore Human Appendicitis Blood- ba.... 4 AspenBio Pharma,Inc. (Nasdaq: APPY ) an emer...evelopment of novel drugs and diagnostics for anim... Edgewater Research Investor Conference, scheduled...
...dle (Nasdaq: KNDL ), a,leading, global full-servi... that President and Chief Operating Officer Christ...eichroeder Hidden Gems Conference. The,conference ...ew York City,Oct. 8-9, 2007. Kendle,s presentation...ern Time. (Logo: http://www.newscom.com/cgi-bin/...
... Acquisition Corp. (OTC,Bulletin Board: ACAQ), a s...a definitive agreement to acquire Lumen Medical In...opment stage biotechnology company that is,develop... the diagnosis of,Pulmonary Embolism, Pulmonary Hy...e trade name PulmoBind. Under the terms of the agr...
Other Biology Technology:AspenBio Pharma to Present the Edgewater Research Investor Conference 2Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 3Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 4
...on's most advanced personal gradient option PCR ma...rd software and a large graphical display for easy...acy and simplicity in thermal cycling, the Px2 inc...lt up on years of PCR experience. The combination ...
Extensor Control & Template from ABgene
Normal Guinea Pig Serum from IDS Ltd
Lambda Control Kit from ABgene
Biology Products: